Eisai Co. Ltd.'s Fiscal Year is From April To March.
The item "Debt-To-Equity-Ratio" stands at 0.277 as of 09/30/2025, the highest value at least since 06/30/2022, the period currently displayed.
As of the end of Eisai Co. Ltd.'s second quarter, the item "Debt To Equity Ratio" stands at 0.277. This represents an increase of 65.00 percent compared to it's value at the end of it's first quarter .
Regarding the One-Year-Change of the series, the current value constitutes an increase of 24.19 percent compared to the value the year prior.
The 1 year change in percent is 24.19.
The 3 year change in percent is 141.68.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Debt To Equity Ratio | 905,699,262,464.00 |
![]() | Johnson & Johnson - Debt To Equity Ratio | 486,508,953,600.00 |
![]() | AbbVie Inc - Debt To Equity Ratio | 399,570,305,024.00 |
![]() | Roche Holding AG - Debt To Equity Ratio | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Debt To Equity Ratio | 280,205,508,085.11 |